H
Hans Fagertun
Publications - 12
Citations - 1493
Hans Fagertun is an academic researcher. The author has contributed to research in topics: Lean body mass & Insulin resistance. The author has an hindex of 9, co-authored 11 publications receiving 1449 citations.
Papers
More filters
Journal ArticleDOI
Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans
Henrietta Blankson,Jacob A. Stakkestad,Hans Fagertun,Erling Thom,Jan Wadstein,Ola Gudmundsen +5 more
TL;DR: The data suggest that conjugated linoleic acid may reduce BFM in humans and that no additional effect on BFM is achieved with doses > 3.4 g CLA/d.
Journal ArticleDOI
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans
Jean-Michel Gaullier,Johan Halse,Kjetil Høye,Knut Kristiansen,Hans Fagertun,Hogne Vik,Ola Gudmundsen +6 more
TL;DR: Long-term supplementation with CLA-FFA or CLA-triacylglycerol reduces BFM in healthy overweight adults, and adverse events did not differ significantly between groups.
Journal ArticleDOI
Supplementation with Conjugated Linoleic Acid for 24 Months Is Well Tolerated by and Reduces Body Fat Mass in Healthy, Overweight Humans
Jean-Michel Gaullier,Johan Halse,Kjetil Høye,Knut Kristiansen,Hans Fagertun,Hogne Vik,Ola Gudmundsen +6 more
TL;DR: This study shows that CLA supplementation for 24 mo in healthy, overweight adults was well tolerated and confirms also that CLA decreases BFM in overweight humans, and may help maintain initial reductions in BFM and weight in the long term.
Journal ArticleDOI
Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers
Grethe Berven,Amund Bye,Ottar Hals,Henrietta Blankson,Hans Fagertun,Erling Thom,Jan Wadstein,Ola Gudmundsen +7 more
TL;DR: The results indicate that CLA in the given dose is a safe substance in healthy populations with regard to the safety parameters investigated and the overall treatment effect of CLA on body weight and BMI was not significant.
Journal ArticleDOI
Body composition analysis by dual X-ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments.
TL;DR: Despite the significant differences in measurement of body composition between DXA fan‐beam instruments, clinically relevant conversion factors can be established.